slides · global inventory
Roadmap
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 3,235
Current window 1,921-1,950
Pages 108
Rows per page 30
Slide type
1,921-1,950 of 3,235
30
MTD = Maximum Tolerated Dose; ORR = Objective Response Rate; ABS = Adenosine Burden Score.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Visualization1 hit
38
The slide outlines a standard oncology clinical trial design (Dose Escalation to RP2D to Dose Expansion).Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
10
The chart uses a horizontal bar format to represent development stages. One bar is orange (EXS4318), while the others are teal.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
12
The slide outlines a standard oncology clinical trial design (Phase 1/2) with a transition point at RP2D (Recommended Phase 2 Dose).Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
06
The slide uses a status-based roadmap structure to track integration progress.First Citizens BancShares | Results Presentation Deck | 57 slides · First Citizens BancShares
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
05
The chart combines a stacked bar chart (production volume) with a line chart (line speed) to show the ramp-up trajectory.Freyr | Results Presentation Deck | 19 slides · FREYR
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
05
The slide uses a Gantt-style visualization to represent clinical trial progress.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Solution1 hit
11
Includes competitive benchmarking context in the footer notes regarding Endocyte and POINT clinical trial data sizes.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Product1 hit
13
The slide outlines a standard 3+3 dose escalation clinical trial design for a radiopharmaceutical.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Product1 hit
09
The slide uses metaphorical imagery (light trails, highway interchange, crosswalk) to represent the product categories.Gogoro | Investor Presentation Deck | 27 slides · Gogoro
Pitch deck Investor relations Beat · Future Products in DevelopmentLoop · Why Now1 hit
07
HeartBeam | Results Presentation Deck | 10 slidesHeartBeam | Results Presentation Deck | 10 slides · HeartBeam
Conference presentation Investor relations Beat · DesireLoop · Why Now1 hit
20
The slide uses a combination of bar charts and a process flow to illustrate growth and efficiency targets.Hugo Boss | Investor Day Presentation Deck | 107 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
47
The slide uses a value-chain style process flow with supporting imagery for each stage.Hugo Boss | Investor Day Presentation Deck | 107 slides · Hugo Boss
Conference presentation Investor relations Beat · VisualizationLoop · Pareto Focus1 hit
12
The slide outlines a progression from Pilot to Ramp-up, detailing truck counts and hydrogen consumption.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Market Size1 hit
10
The slide outlines a strategic progression from pilot to full ramp-up, supported by specific operational metrics.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Rising Success1 hit
12
The slide uses icons to categorize milestones into Organization, Fuel cell, and Vehicle.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Rising Success1 hit
13
The slide uses a matrix-like structure to map strategic initiatives against time and recurrence.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · The Breakthrough1 hit
05
The table uses a standard pharmaceutical pipeline format, categorizing by clinical vs preclinical status and therapy type (CAR-T vs TSTx).Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
09
The slide uses a two-column layout to separate milestones by drug candidate.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
22
The slide uses a structured table-like layout to map clinical progress against specific disease indications.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
33
Shows two parallel tracks: monotherapy and combination therapy with tislelizumab.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
06
The table uses a standard pharmaceutical pipeline layout with clinical and preclinical segments.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem & Complication1 hit
12
The slide uses a two-column layout to separate milestones by drug candidate.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
25
The slide uses a structured table format to map clinical trial progress against specific disease indications.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
36
Shows two parallel clinical tracks: monotherapy and combination with tislelizumab.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
11
Includes a footer citing FDA approval precedents for similar patient population sizes.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
13
The slide uses a standard pharmaceutical pipeline table format.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
14
The slide uses a two-column layout to track progress for two distinct drug programs.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
27
Includes a footer citing FDA approval precedents for patient population sizes.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
38
The slide uses a process flow diagram to show the progression of clinical trials for two different treatment regimens.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations 1 hit